BIOCRYST PHARMACEUTICALS, INC.: cash_and_equivalents

Value{"amount": 146215000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2023-06-30)
Statuscurrent
EntityBIOCRYST PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001628280-23-027820
Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000882796/cash-and-equivalents/2023-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/372c4a08-f9d0-4677-8a89-731e85681514

History